Schedule 13G ownership disclosure
Emergent BioSolutions Inc
Common Stock · CUSIP: 29089Q105
Event date: 2026-03-13
- Filing-level shares
- 0
- Percent of class
- 0%
- The Vanguard Group
Shares: 0 · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000102909-26-001106
- Form type
- SCHEDULE 13G/A
- Filer
- Emergent BioSolutions Inc.
- CIK
- CIK 1367644
- Filed
- Mar 26, 2026
- Reporting period
- Mar 13, 2026
- Description
- Schedule 13G beneficial ownership